LEDAS Blog

  • Digital Medicine 

What Statistics Can Tell Us About SARS-CoV-2 Test Results

Antibody testing at LEDAS shows good results. What does it mean?

Jul 20, 2020 Nikolay Snytnikov

To better estimate the situation with СOVID-19 within our company LEDAS, we decided to make antibody testing available to our employees who work remotely since March. Fifty-three of our 70+ employees were interested, and so we organized out-of-lab testing thanks to Invitro’s laboratory service. Both IgM (early antibodies) and IgG (late antibodies) were examined, and the results were simple: all had zero positives for IgM, and one employee was positive for IgG.

We were able to congratulate ourselves for the zero result in early antibodies, meaning we are quite safe. But now we needed to focus on the late antibodies, as they provide more interesting information. Since we at LEDAS are now involved in more medical software projects, we considered this an opportunity to apply statistics to our ...

Read more

LEDAS customer map

May 24, 2020 Alexey Ershov

The geography of the locations of our customers has changed considerably during the 20+ years of LEDAS’ history.

From looking at the map of our customers (below), you may think that we began in our home country and then expanded abroad. In fact, the reverse is true, because in its first years LEDAS mostly provided CAD and CAM software development services in Europe, namely to Dassault Systèmes from France.

In the beginning, we concentrated on developing geometric solvers and engines, a rather narrow field, yet very sensitive to quality. Over the following years, overall CAD software market was our primary focus.

In late 2000s, LEDAS Geometric Solver (LGS) was our flagship product, along with our high-quality R&D (research and development) services for CAD and PLM. Many ...

Read more


Show: 10 20 50 All